Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arud Center for Addiction Medicine is a specialized healthcare institution based in Zurich, Switzerland, dedicated to the treatment of substance-use disorders and behavioral addictions. Founded in 1991, the center is a pioneer in harm reduction and provides integrated medical, psychiatric, and social services. Its clinical offerings include opioid agonist treatments (OAT), psychotherapy, and specialized care for infectious diseases like Hepatitis C and HIV. Arud also functions as a research hub, participating in clinical trials and public health studies to advance addiction medicine and improve patient outcomes. The organization is a key player in the Swiss drug policy framework, emphasizing low-threshold access to care and the destigmatization of addiction.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arud Center for Addiction Medicine.